S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%
Next Bullish Trade
Sign in
WAT

Waters Corporation WAT

$368.98 -9.21 (-2.44%)
Neutral · -0.21σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · WAT

Momentum reads · latest daily bar
Last
$368.98
-9.21 (-2.44%)
Mkt cap
$36.2B
Healthcare
RSI(14)
50.0
neutral
Stochastic %K
50.3
neutral
MFI(14)
66.8
neutral
ADX(14)
20.3
building

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $1.3B $-0.1B $-0.0B $-0.0B -5.7% -3.7%
2025-12-31 $0.9B $0.2B $0.3B $0.1B 24.2% 29.0%
2025-09-30 $0.8B $0.1B $0.2B $0.2B 18.6% 24.0%
2025-06-30 $0.8B $0.1B $0.2B $0.0B 19.1% 24.4%
2025-03-31 $0.7B $0.1B $0.2B $0.2B 18.3% 23.0%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare WAT vs peers

Line WAT up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing WAT no peers yet — add up to 4 below
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with WAT

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-05 2.70 2.31 +17.0% +2.0%
2026-02-09 4.53 4.51 +0.5% -0.3%
2025-11-04 3.40 3.22 +5.5% +1.3%
2025-08-04 2.95 2.94 +0.3% -1.5%
2025-05-06 2.25 2.22 +1.2% +1.9%
2025-02-12 4.10 4.03 +1.7% -0.7%
2024-11-01 2.93 2.68 +9.4% +0.0%
2024-07-31 2.63 2.56 +2.6% +4.8%
2024-05-07 2.21 2.09 +5.5% -0.7%
2024-02-06 3.62 3.55 +1.9% -2.1%
2023-11-07 2.84 2.55 +11.3% -1.9%
2023-08-02 2.80 2.59 +8.1% -0.1%
2023-05-09 2.49 2.62 -5.1% -1.6%
2023-02-15 3.84 3.74 +2.6% -2.8%
2022-11-01 2.64 2.58 +2.4% -3.8%
2022-08-02 2.75 2.67 +3.1% -0.5%
2022-05-03 2.80 2.34 +19.8% +4.8%
2022-02-01 3.67 3.49 +5.3% +2.0%
2021-11-02 2.66 2.36 +12.7% -0.4%
2021-08-03 2.60 2.28 +13.8% +0.6%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
WAT ★ $36B 48.1 22.4 9.6 36.4 2.4 55.2% 91.4% — -1.39%
LLY $1,051B 41.5 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 31.8 19.2 0.9 20.2 4.0 18.8% 2.0% 0.7% 4.57%
JNJ $609B 29.0 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.8 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 44.29%

HolderShares% out
Blackrock Inc. 8,543,014 8.70%
Vanguard Capital Management LLC 6,378,775 6.50%
Vanguard Portfolio Management LLC 4,754,185 4.84%
T. Rowe Price Investment Management, 4,663,879 4.75%
Massachusetts Financial Services Co. 4,630,118 4.72%
State Street Corporation 4,362,010 4.44%
Fundsmith LLP 3,212,075 3.27%
Geode Capital Management, LLC 2,646,458 2.70%
Invesco Ltd. 2,168,285 2.21%
Alliancebernstein L.P. 2,116,737 2.16%

Insider activity · 90d

2 buys / 0 sells · ratio 2.0 · Finnhub

  • Knight Heather BUY 1,281
  • Jiang Wei BUY 3,573
  • Carpio Robert L III F 3,426 @ $369.18
  • Chaubal Amol F 7,623 @ $352.21

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$349.0
Mean
$413.125
High
$460.0
Analysts
24
Recommendation distribution · period 2026-07-01
8
8
14
Revision trend (2026-04-01 → 2026-07-01): net 16 → 16 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-02 PRIMARY DOCUMENT view ·
4 2026-07-02 PRIMARY DOCUMENT view ·
4 2026-06-25 PRIMARY DOCUMENT view ·
8-K 2026-05-22 8-K view ·
4 2026-05-14 PRIMARY DOCUMENT view ·
10-Q 2026-05-12 10-Q view ·
8-K 2026-05-05 8-K view ·
DEF 14A 2026-04-09 DEF 14A view ·
4 2026-04-07 PRIMARY DOCUMENT view ·
4 2026-04-02 PRIMARY DOCUMENT view ·
4 2026-04-02 PRIMARY DOCUMENT view ·
8-K 2026-03-23 8-K view ·
4 2026-03-18 PRIMARY DOCUMENT view ·
8-K 2026-03-16 8-K view ·
4 2026-03-10 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
4 2026-02-27 PRIMARY DOCUMENT view ·
10-K 2026-02-23 10-K view ·
8-K 2026-02-09 8-K view ·
8-K 2026-02-09 8-K view ·
4 2026-02-06 PRIMARY DOCUMENT view ·
4 2026-02-06 PRIMARY DOCUMENT view ·
4 2026-02-06 PRIMARY DOCUMENT view ·
4 2026-02-06 PRIMARY DOCUMENT view ·
8-K 2026-01-27 8-K view ·
8-K 2026-01-16 8-K view ·
8-K 2026-01-12 8-K view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2025-11-07 PRIMARY DOCUMENT view ·
10-Q 2025-11-04 10-Q view ·
8-K 2025-11-04 8-K view ·
4 2025-10-02 PRIMARY DOCUMENT view ·
4 2025-10-02 PRIMARY DOCUMENT view ·
10-Q 2025-08-04 10-Q view ·
8-K 2025-08-04 8-K view ·
8-K 2025-07-14 8-K view ·
8-K 2025-07-14 8-K view ·

About WAT

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, …

Options picks · WAT

ITM + OTM ideas from the latest scan

Loading…

Congress trades · WAT

STOCK Act disclosures

Loading…

SEC filings & insiders · WAT

EDGAR · live

Loading…

Holders · WAT

Institutions & insider activity

Loading…